Market price fluctuation risk for securities and investment securities
First written in FY2016. 11 of 22 entries say "Mitigated", first in FY2021. Latest entry: 2026-08-14.
The whole theme swung hardest in 2019: 31 of 92 companies on the "Worse" side.
22 other companies' latest entry also says "Mitigated".
- 2026-08-14MitigatedEarnings
「Increase in valuation difference on other securities: ¥637 million」
The valuation difference on other securities increased, indicating an improvement from the end of the previous fiscal year in valuation differences arising from changes in market prices. - FY2026MitigatedAnnual report
「¥1,865 million increase in valuation difference on other securities」
The valuation difference on other securities increased from ¥1,618 million at the end of the previous fiscal year to ¥3,483 million. It has improved from the period of decline in the valuation difference seen in the previous six-month period. - FY2026-H1MitigatedAnnual report
「Valuation difference on other securities △ 32 455」
The valuation difference on other securities changed from a decrease of ¥32 million in the same period of the previous year to an increase of ¥455 million in the current six-month period. The valuation difference resulting from market price fluctuations has improved from the previous six-month period. - FY2025-H1WorsenedAnnual report
「Valuation difference on other securities 625 △32」
The valuation difference on other securities changed from an increase of ¥625 million in the same period of the previous year to a decrease of ¥32 million in the current six-month period. The valuation difference resulting from market price fluctuations has shifted toward deterioration from the improvement seen in the previous period. - FY2024-Q3MitigatedAnnual report
「¥986 million increase in valuation difference on other securities」
The valuation difference on other securities increased from ¥507 million at the end of the previous consolidated fiscal year to ¥1,493 million. No loss on valuation of investment securities was recorded during the cumulative period for the current quarter, and the adverse effects of market price fluctuations have eased. - FY2024-Q2MitigatedAnnual report
「Increase factors: ¥625 million increase in valuation difference on other securities」
The valuation difference on other securities increased from ¥507 million at the end of the previous consolidated fiscal year to ¥1,133 million. No loss on valuation of investment securities was recorded in the current quarter, and the adverse effects of market price fluctuations have eased. - FY2024-Q1MitigatedAnnual report
「Increase factors: ¥429 million increase in valuation difference on other securities」
The valuation difference on other securities increased from ¥507 million at the end of the previous consolidated fiscal year to ¥936 million. The valuation difference resulting from market price fluctuations is improving, and no loss on valuation of investment securities was recorded in the current quarter. - FY2023MitigatedAnnual report
「¥133 million increase in valuation difference on other securities」
The valuation difference on other securities increased from ¥373 million at the end of the previous fiscal year to ¥507 million, while the ¥89 million loss on valuation of investment securities recorded in the previous fiscal year was not recorded in the current fiscal year. The adverse effects of market price fluctuations eased. - FY2023-Q3MitigatedAnnual report
「¥63 million increase in valuation difference on other securities」
The valuation difference on other securities increased by ¥63 million, while the ¥90 million loss on valuation of investment securities recorded in the same period of the previous year was not recorded in the cumulative results for the current quarter. The adverse effects of market price fluctuations have eased from the period in which valuation losses were recorded in the previous period. - FY2023-Q2MitigatedAnnual report
「Valuation difference on other securities 88 52」
The valuation difference on other securities increased by ¥52 million during the current quarter, from ¥373 million at the end of the previous consolidated fiscal year to ¥425 million. No loss on valuation of investment securities was reported, and the adverse effects have eased from the period in which valuation losses were recorded in the previous period. - FY2023-Q1Decrease in valuation differenceAnnual report
「Valuation difference on other securities 102 △ 26」
The valuation difference on other securities changed from an increase of ¥102 million in the same period of the previous year to a decrease of ¥26 million in the current quarter. Although no loss on valuation of investment securities was reported, the effects of market price fluctuations are reflected in the valuation difference. - FY2022-Q3MaterialisedAnnual report
「Loss on valuation of investment securities 99 90」
A ¥90 million loss on valuation of investment securities was recorded as an extraordinary loss. Although this was down from ¥99 million in the same period of the previous year, the effects of market price fluctuation risk continued to be reflected in the cumulative results for the current quarter. - FY2022-Q2Elimination of valuation losses and increase in holdingsAnnual report
「Loss on valuation of investment securities 105 －」
The ¥105 million loss on valuation of investment securities recorded in the same quarter of the previous year was not recorded in the current quarter. Meanwhile, investment securities increased by ¥613 million from the end of the previous consolidated fiscal year. The impact of valuation losses eased, but the balance of holdings increased. - FY2022-Q1MitigatedAnnual report
「Increase factors: ¥516 million increase from net income attributable to owners of the parent and ¥102 million increase in valuation difference on other securities」
The valuation difference on other securities increased by ¥102 million, and no loss on valuation of investment securities was recorded in the current quarter. The adverse effects of market price fluctuations have eased from the period in which valuation losses were recorded in the previous period. - FY2021MitigatedAnnual report
「Total 4,601 4,265 335」
The valuation difference on other securities shifted from an acquisition-cost shortfall of ¥109 million in the previous fiscal year to a valuation gain of ¥335 million in the current fiscal year, easing the adverse effects of market price fluctuations. - FY2021-Q3RestatedAnnual report
「Impairment Loss on Investment Securities」
A ¥99 million loss on valuation of investment securities was recorded as an extraordinary loss, and the effects of market price fluctuations continued to be reflected in the results. - FY2021-Q2MaterialisedAnnual report
「Loss on valuation of investment securities － 105」
A ¥105 million loss on valuation of investment securities was recorded as an extraordinary loss, with the effects of market price fluctuation risk reflected in the results. - FY2021-Q1MaterialisedAnnual report
「Loss on valuation of investment securities － 97」
A ¥97 million loss on valuation of investment securities was recorded as an extraordinary loss, with the effects of market price fluctuation risk reflected in the results. - FY2020MaterialisedAnnual report
「Total 2,165 2,275 △109」
For other securities, the amount recorded on the consolidated balance sheet at the end of the current fiscal year was ¥109 million below acquisition cost, quantifying the deterioration in valuation differences caused by market price fluctuations. - FY2019RestatedAnnual report
「Marketable securities and investment securities consist mainly of bonds classified as other securities and shares in companies with which the Group has business relationships. Although they are exposed to the risk of fluctuations in market prices, regularly monitored fair values are reported to the Board of Directors.」
Continues to manage the risk of market price fluctuations by regularly monitoring fair value and issuers' financial condition and reporting them to the Board of Directors. - FY2017RestatedAnnual report
「Marketable securities and investment securities consist mainly of bonds classified as other securities and shares in companies with which the Group has business relationships. Although they are exposed to the risk of fluctuations in market prices, regularly monitored fair values are reported to the Board of Directors.」
Continues to manage the risk of market price fluctuations by regularly monitoring fair value and issuers' financial condition and reporting them to the Board of Directors. - FY2016First statedAnnual report
「Marketable securities and investment securities consist mainly of bonds classified as other securities and shares in companies with which the Group has business relationships. Although they are exposed to the risk of fluctuations in market prices, regularly monitored fair values are reported to the Board of Directors.」
Describes a management approach involving regular monitoring of fair value and issuers' financial condition and reviewing holdings in light of market conditions and relationships with business partners.